Established in 2000 and based in Shanghai, Zensun is a biopharmaceutical company developing bio-therapeutic products.
Established in 2000 and based in Shanghai, China, Zensun is a biopharmaceutical company developing bio-therapeutic products. Its six product pipelines cover cardiovascular, gastrointestinal, urological and nervous system fields, including treatments for heart failure and Alzheimer's disease. The company was listed on the National Equities Exchange and Quotations in May 2017. In January 2024 it raised CNY 89.99 million in strategic investment from Dianshi huayi Capital and Ihang Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in